These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 31486485)

  • 1. LncRNA ITGB1 promotes the development of bladder cancer through regulating microRNA-10a expression.
    Dai L; Chai CM; Shen TY; Tian Y; Shang ZQ; Niu YJ
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6858-6867. PubMed ID: 31486485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-424-5p inhibits the development of non-small cell LCa by binding to ITGB1.
    Xu ZL; Zhang M; Chen SX; Qiu M; Zhang Q; Gao LP; Li JDX
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8921-8930. PubMed ID: 31696479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA AFAP1-AS1 promotes proliferation ability and invasiveness of bladder cancer cells.
    Gui JQ; Zhang C; Yang HB; Yu YW; Cui MR; Wang WS
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8747-8755. PubMed ID: 32964963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA HOXA-AS2 regulates microRNA-216a-5p to promote malignant progression of non-small cell lung cancer.
    Cui TJ; Lin GS; Dai YM; Zheng JP; Chen Z; Chen Q; Zheng Y; Lin X
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):264-273. PubMed ID: 31389597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TATDN1 promotes the development and progression of breast cancer by targeting microRNA-140-3p.
    Yu XY; Tian JR; Yang D; Tan HR
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5293-5300. PubMed ID: 31298381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bladder Cancer Progression Is Suppressed Through the Heart and Neural Crest Derivatives Expressed 2-Antisense RNA 1/microRNA-93-5p/Defective in Cullin Neddylation 1 Domain Containing 3 Axis.
    Wu X; Xu Q; Li T; Wei Y; Zeng R; Lin R; Xu L; Ye L; Liu Z
    Appl Biochem Biotechnol; 2023 Jul; 195(7):4116-4133. PubMed ID: 36656536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circ_0061140 promotes metastasis of bladder cancer through adsorbing microRNA-1236.
    Feng F; Chen AP; Wang XL; Wu GL
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5310-5319. PubMed ID: 32495864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA H19 promotes the development of hepatitis B related hepatocellular carcinoma through regulating microRNA-22 via EMT pathway.
    Li L; Han T; Liu K; Lei CG; Wang ZC; Shi GJ
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5392-5401. PubMed ID: 31298392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA GIHCG regulates microRNA-1281 and promotes malignant progression of breast cancer.
    Fan LY; Shi KY; Xu D; Ren LP; Yang P; Zhang L; Wang F; Shao GL
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10842-10850. PubMed ID: 31858553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA SNHG7 promotes development of breast cancer by regulating microRNA-186.
    Luo X; Song Y; Tang L; Sun DH; Ji DG
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7788-7797. PubMed ID: 30536320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA LINP1 promotes malignant progression of pancreatic cancer by adsorbing microRNA-491-3p.
    Chen AY; Zhang K; Liu GQ
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9315-9324. PubMed ID: 33015772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microarray expression profiles analysis revealed lncRNA OXCT1-AS1 promoted bladder cancer cell aggressiveness via miR-455-5p/JAK1 signaling.
    Chen JB; Zhu YW; Guo X; Yu C; Liu PH; Li C; Hu J; Li HH; Liu LF; Chen MF; Chen HQ; Xiong-Bing Z
    J Cell Physiol; 2019 Aug; 234(8):13592-13601. PubMed ID: 30609030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA WTAPP1 promotes proliferation of laryngeal carcinoma cells through regulating microRNA-592.
    Shi XY; Lin JJ; Ge XJ; Shi Y
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9532-9540. PubMed ID: 33015795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclic RNA hsa_circ_0091017 inhibits proliferation, migration and invasiveness of bladder cancer cells by binding to microRNA-589-5p.
    Zhang L; Xia HB; Zhao CY; Shi L; Ren XL
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):86-96. PubMed ID: 31957821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA FAL1 promotes the development of oral squamous cell carcinoma through regulating the microRNA-761/CRKL pathway.
    Ye J; Jiao Y
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5779-5786. PubMed ID: 31298329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NOTCH1 regulates the proliferation and migration of bladder cancer cells by cooperating with long non-coding RNA HCG18 and microRNA-34c-5p.
    Xu Z; Huang B; Zhang Q; He X; Wei H; Zhang D
    J Cell Biochem; 2019 Apr; 120(4):6596-6604. PubMed ID: 30426533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA DARS-AS1 regulates microRNA-129 to promote malignant progression of thyroid cancer.
    Zheng W; Tian X; Cai L; Shen YM; Cao QS; Yang JY; Tian GY
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10443-10452. PubMed ID: 31841198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA CASC11 promotes the development of esophageal carcinoma by regulating KLF6.
    Chen SG; Wang CH; He RQ; Xu RY; Ji CB
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8878-8887. PubMed ID: 31696474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA ARAP1-AS1 promotes the progression of bladder cancer by regulating miR-4735-3p/NOTCH2 axis.
    Teng J; Ai X; Jia Z; Wang K; Guan Y; Guo Y
    Cancer Biol Ther; 2019; 20(4):552-561. PubMed ID: 30404578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-548c-5p inhibits the proliferation of breast cancer cells through regulating Wnt/β-catenin signaling pathway.
    He SZ; Wang Q
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3795-3804. PubMed ID: 32329856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.